Related Experiment Video

Updated: Aug 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Therapy of hepatitis C in patients with HIV infection

Tami Daugherty1, Maurizio Bonacini

  • 1California Pacific Medical Center, 2340 Clay Street, 2nd Floor, San Francisco, CA 94115, USA. daugheT@sutterhealth.org

Expert Review of Anti-Infective Therapy
|June 16, 2005
PubMed

Insights

Hepatitis C treatment in HIV patients is crucial for managing faster disease progression and potential liver damage. Current standards use peginterferon and ribavirin, with higher doses potentially improving outcomes.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • Hepatitis C affects approximately one-third of individuals with Human Immunodeficiency Virus (HIV).
  • Hepatitis C progression can be accelerated in immunosuppressed HIV patients, though mortality has decreased with antiretroviral therapy.
  • Coinfection is linked to elevated liver tests and potentially reduced CD4+ T-cell recovery during treatment.

Purpose of the Study:

  • To review the importance and therapeutic strategies for Hepatitis C in HIV-coinfected patients.
  • To discuss the standard of care and potential alternative treatments for Hepatitis C in this population.

Main Methods:

  • Literature review of existing data on Hepatitis C and HIV coinfection.
  • Analysis of therapeutic outcomes with peginterferon and ribavirin combinations.
  • Evaluation of maintenance therapy for non-responders.

Main Results:

  • Standard therapy involves peginterferon and a fixed dose of ribavirin (800 mg/day).
  • Higher ribavirin doses may enhance virologic outcomes.
  • Peginterferon monotherapy is a potential strategy for managing liver fibrosis in non-responders, pending further data.

Conclusions:

  • Hepatitis C therapy is vital in HIV-coinfected individuals due to potential for rapid disease progression.
  • Optimizing ribavirin dosage and considering maintenance therapy are key considerations.
  • Further controlled studies are needed to establish formal recommendations for maintenance therapy in coinfected patients.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...